Stevanato Group S.p.A STVN
NYSE STVN
$22.60 +0.25 (+1.12%)
At close: Aug 21, 2026 · 4:00 PM EDT

Stevanato Group S.p.A (STVN) Total Non-Current Liabilities (2020 - 2026)

Stevanato Group S.p.A (STVN) posted quarterly Total Non-Current Liabilities of -$89.9 million for Q1 2026, down 3.36% year-over-year from -$93.0 million in Q1 2025, and down 2.44% quarter-over-quarter from -$87.8 million in Q4 2025.

Stevanato Group S.p.A (STVN) Total Non-Current Liabilities (2020 - 2026) Analysis & Trends

Stevanato Group S.p.A (STVN) has reported Total Non-Current Liabilities for 7 consecutive years, with -$89.9 million the latest figure, recorded in Q1 2026.

  • In Q1 2026, Total Non-Current Liabilities fell 3.36% year-over-year to -$89.9 million; the TTM figure through Mar 2026 stood at -$89.9 million (down 3.36% YoY), while the FY2025 annual figure was -$87.8 million, up 3.71% from the prior year.
  • Total Non-Current Liabilities declined to -$89.9 million in Q1 2026 per STVN's latest filing, from -$87.8 million in the prior quarter.
  • Across five years, Total Non-Current Liabilities topped out at -$39.3 million in Q2 2022 and bottomed at -$91.2 million in Q3 2025.
  • Historically, Total Non-Current Liabilities has averaged -$73.3 million across 5 years, with a median of -$78.8 million in 2024.
  • Annual changes were most pronounced in 2022 — Total Non-Current Liabilities plunged 116.16% — and 2025, when it rose 3.71%.
  • Stevanato Group S.p.A's Total Non-Current Liabilities stood at -$54.0 million in 2022, then tumbled by 38.55% to -$74.8 million in 2023, then slipped by 21.9% to -$91.2 million in 2024, then climbed by 3.71% to -$87.8 million in 2025, then declined by 2.44% to -$89.9 million in 2026.
  • Business Quant data shows STVN's Total Non-Current Liabilities at -$89.9 million in Q1 2026, -$87.8 million in Q4 2025, and -$91.2 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Intuitive Surgical 134.13 Bn 128.91 Bn 1.96 Bn 1.92 Bn
2 Becton Dickinson 52.76 Bn 51.90 Bn 2.32 Bn 48.34 Bn
3 Alcon 35.81 Bn 34.46 Bn 1.68 Bn 6.34 Bn
4 Resmed 33.72 Bn 32.25 Bn 861.22 Mn 985.45 Mn
5 Medline 29.38 Bn 26.70 Bn 2.22 Bn 17.56 Bn
6 West Pharmaceutical Services 25.00 Bn 24.57 Bn 329.20 Mn 996.30 Mn
7 Solventum 15.46 Bn 15.06 Bn 1.29 Bn 8.96 Bn
8 Cooper Companies 14.88 Bn 14.74 Bn 735.40 Mn 3.98 Bn
9 Baxter International 13.58 Bn 11.43 Bn 1.03 Bn 12.41 Bn
10 Stevanato Group S.p.A 6.18 Bn 6.07 Bn 100.91 Mn -89.27 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 -89.27 Mn
Mar 31, 2026 -89.91 Mn
Dec 31, 2025 -87.77 Mn
Sep 30, 2025 -91.19 Mn
Jun 30, 2025 -88.41 Mn
Mar 31, 2025 -86.99 Mn
Dec 31, 2024 -91.15 Mn
Sep 30, 2024 -81.38 Mn
Jun 30, 2024 -78.83 Mn
Mar 31, 2024 -78.65 Mn
Dec 31, 2023 -74.78 Mn
Sep 30, 2023 -80.45 Mn
Jun 30, 2023 -74.05 Mn
Mar 31, 2023 -57.32 Mn
Dec 31, 2022 -53.97 Mn
Sep 30, 2022 -51.02 Mn
Jun 30, 2022 -39.27 Mn
Mar 31, 2022 -41.41 Mn
Dec 31, 2021 -41.53 Mn
Sep 30, 2021 315.78 Mn